Expansion plans include a new facility, Enmetazobactam launch, and mergers for sustainable growth and reduced import reliance. Orchid Pharma, which is seeing a turnaround under its new promoter Dhanuka Group, aspires to be a fully integrated powerhouse of cephalosporin antibiotics, the company's top executive said
Orchid Pharma, the Chennai-based drug maker on Tuesday said it has entered into a technology transfer agreement with a leading multinational biotechnology company for its fermentation based ‘7ACA project’ under the production linked incentive (PLI) scheme. nnnRead more at: nhttps://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/orchid-pharma-enter-tech-transfer-pact-to-make-key-cephalosporin-intermediate/articleshow/101676645.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
New Delhi, Drug firm Venus Remedies on Monday said it has received good manufacturing practices (GMF) certification from the Saudi drug regulator for its production facilities at Baddi, Himachal Pradesh. The Saudi Food and Drug Authority (SFDA) granted the certification which includes first-time approval for pre-filled enoxaparin syringes and general injection facilities, the company said in a regulatory filing.
The Indian Pharmacopoeia Commission (IPC), which is the National Coordination Centre (NCC) for Pharmacovigilance Programme of India (PvPI), has flagged a drug safety alert revealing that dimethyl fumarate which is indicated for relapsing-remitting multiple sclerosis is associated with adverse drug reaction alopecia while cefazolin, a cephalosporin antibiotic is linked with acute generalised exanthematous pustulosis (AGEP).
Sandoz, a Novartis division, has successfully completed the acquisition of GSK’s cephalosporin antibiotics business. The transaction, which including leading global brand Zinnat, complements Sandoz leadership in generic penicillins with a leading position in cephalosporins.
Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies, is planning to launch cephalosporin products soon.
FDA gets specific on data integrity rules; Lupin, Dishman tagged with 483s
US FDA completes inspection of Lupin’s Mandideep location
NEW DELHI: Drug major LupinNSE -0.73 % Wednesday said the US health regulator has made a total of 22 observations after inspection of its facilities loacated at Mandideep in Madhya Pradesh.
Pharmaceuticals Export Promotion Council of India, a body under Ministry of Commerce and Industry, today expressed apprehension that a larger conspiracy is unfolding to defame Indian pharma industry in international markets.